Intraventricular Hemorrhage

Primary Hemorrhagic Event

• Rupture of penetrating arteries (lenticulostriate arteries from middle cerebral artery, perforating branches of basilar artery) or direct ventricular sources due to elevated intracranial pressure, coagulopathy, or vascular malformation
• Initial bleeding into deep brain parenchyma with secondary rupture into adjacent ventricular system
• Direct hemorrhage into ventricular cavities from ependymal vascular abnormalities (less common in adults)

Obstructive Hydrocephalus Mechanism

• Blood clot formation within narrow ventricular passages (interventricular foramina, cerebral aqueduct, fourth ventricular outlet) obstructs cerebrospinal fluid (CSF) flow
• Acute obstruction → rapid intracranial pressure elevation due to impaired CSF absorption and continued production
• Ventricular distention causing stretching of periventricular white matter and disruption of subependymal structures
• Intraventricular blood exerts direct mass effect and inflammatory response in confined space

Cytotoxic and Inflammatory Cascade

• Hemoglobin and heme degradation products (bilirubin, iron) trigger oxidative stress and lipid peroxidation in periventricular tissue
• Activation of microglial cells and astrocytes with release of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6)
• Disruption of blood-brain barrier integrity increasing vasogenic edema
• Thrombin generation within clot promotes glial activation and neuronal apoptosis
• Iron-mediated free radical formation causing delayed neuronal death days to weeks after initial hemorrhage

Secondary Brain Injury

• Increased intracranial pressure from blood, clot expansion, and hydrocephalus → decreased cerebral perfusion pressure and ischemia
• Ventricular pressure elevation compressing brainstem structures (uncal herniation risk)
• Periventricular ischemia from microvascular compression and metabolic derangement

Hypertension-Related (Most Common)

• Chronic hypertension causing lipohyalinosis and microaneurysm formation in deep penetrating arteries
• Acute severe hypertension precipitating vessel rupture
• Accounts for 50-60% of adult IVH cases

Anticoagulation and Coagulopathy

• Warfarin therapy (INR >4 dramatically increases risk)
• Direct oral anticoagulants (DOACs: apixaban, rivaroxaban, dabigatran)
• Heparin and low-molecular-weight heparin
• Thrombocytopenia (<50,000/μL) or platelet dysfunction
• Disseminated intravascular coagulation (DIC)
• Hemophilia and other inherited coagulopathies

Cerebral Amyloid Angiopathy

• Amyloid-β deposition in cortical and leptomeningeal vessels
• Progressive vessel fragility with recurrent microhemorrhages
• Predominantly affects lobar hemorrhages but can extend to ventricles

Structural Vascular Lesions

• Arteriovenous malformations (AVMs) with high-flow shunting
• Cerebral aneurysms (especially posterior communicating and basilar apex locations)
• Cavernous malformations in ventricular/periventricular regions
• Dural arteriovenous fistulas

Hemorrhagic Transformation of Ischemic Stroke

• Reperfusion injury after thrombolytic therapy (alteplase, tenecteplase)
• Mechanical thrombectomy-induced vessel rupture
• Large infarct volume with subsequent bleeding

Hemorrhagic Tumor

• Primary glioblastoma with spontaneous hemorrhage
• Secondary hemorrhage from metastatic disease (melanoma, choriocarcinoma, renal cell carcinoma)
• Hematologic malignancies with leukostasis

Infection

• Bacterial endocarditis with septic emboli and mycotic aneurysm rupture
• Meningitis-induced vasculitis and vessel compromise
• Viral hemorrhagic fevers

Substance Use

• Cocaine and amphetamine induced acute hypertension and vasculitis
• Sympathomimetic agents causing acute blood pressure elevation

Prematurity-Specific (Neonatal IVH)

• Germinal matrix hemorrhage from immature fragile vasculature
• Fluctuating cerebral blood flow from respiratory distress syndrome
• Sudden increases in intracranial pressure (suctioning, rapid fluid boluses)

Other Risk Factors

• Advanced age (>60 years)
• Male predominance (2:1 ratio)
• Diabetes mellitus
• Chronic liver disease with coagulopathy
• Head trauma with vessel disruption

Acute Onset Symptoms

• Sudden severe headache (often "thunderclap" quality, worst headache of life)
• Acute altered mental status progressing to coma in severe cases
• Sudden loss of consciousness
• Rapid neurologic decline over minutes to hours (distinguishes from ischemic stroke)

Motor and Sensory Findings

• Hemiparesis or hemiplegia contralateral to hemorrhage
• Ipsilateral loss of conjugate gaze
• Nystagmus (especially downbeating if fourth ventricular involvement)
• Sensory deficits corresponding to hemisphere of origin

Brainstem Signs (indicating transtentorial herniation)

• Bilateral pupillary dilation (midbrain compression)
• Loss of pupillary light reflexes
• Bilateral Babinski signs
• Decorticate (flexor) posturing progressing to decerebrate (extensor) posturing
• Respiratory changes (Cheyne-Stokes initially, then central hyperventilation, then apneic)

Posterior Fossa Signs

• Ataxia and gait disturbance (cerebellar involvement)
• Trigeminal neuralgia-like facial pain (fifth nerve irritation)
• Cranial nerve palsies (CN IV, VI involvement common)

Meningeal Signs

• Neck stiffness and photophobia
• Headache exacerbated by neck flexion
• Positive Kernig and Brudzinski signs (from meningeal irritation by blood)

Vital Sign Abnormalities

• Hypertension (from sympathetic surge and Cushing reflex from increased intracranial pressure)
• Bradycardia (from raised intracranial pressure)
• Hyperthermia (from hypothalamic damage)

Speech and Language

• Dysarthria from brainstem or cerebellar involvement
• Aphasia (dominant hemisphere hemorrhage)
• Mutism (midline/third ventricular involvement)

Neuroimaging - Gold Standard

• Non-contrast head CT (STAT): Hyperdense blood in ventricular system; most sensitive in acute phase (hours). Demonstrates:
• Location and extent of ventricular blood (grade by Graeb or Barth scales)
• Degree of ventricular dilation (hydrocephalus assessment)
• Midline shift and mass effect
• Source (parenchymal hemorrhage extending into ventricles vs. primary ventricular hemorrhage)

• MRI brain with gradient echo/susceptibility-weighted sequences: Superior to CT for subacute hemorrhage (3-20 days); detects hemosiderin deposits indicating prior microhemorrhages; identifies underlying structural lesions (AVMs, cavernomas)

• CT/MR angiography: Essential to exclude aneurysm, AVM, or tumor as hemorrhage source; obtain in all non-hypertensive IVH cases and young hypertensive patients

Lumbar Puncture (CSF Analysis)

• Indicated only after exclusion of mass effect and safe for LP (via imaging)
• Grossly bloody CSF (xanthochromia if >12 hours old)
• Elevated protein (hundreds to thousands mg/dL from hemoglobin)
• Normal or mildly elevated glucose (distinguishes from bacterial meningitis)
• RBC-predominant pleocytosis

Laboratory Studies

• Coagulation studies: PT/INR, PTT, platelet count, fibrinogen
• CBC: Baseline hemoglobin/hematocrit; assess for thrombocytopenia
• Comprehensive metabolic panel: Electrolytes, renal function (contrast administration safety), glucose
• Lactate dehydrogenase (LDH): Elevated from hemolysis, prognostic significance
• Type and crossmatch: For potential transfusion if anemia develops

Diagnostic Criteria/Severity Grading

• Modified Graeb Scale (0-12 points):
• Grade 0: No IVH
• Grade I: Intraventricular blood without ventricular dilation (1-2 points each for bilateral ventricles)
• Grade II: IVH with ventricular dilation (2-4 points each)
• Grade III: IVH filling >50% of ventricular system (4 points)
• Predictive of mortality and functional outcome

• Barth Score: Combines IVH grade with Glasgow Coma Scale (GCS); superior prognostic accuracy

Continuous Monitoring Indicators

• Intracranial pressure monitoring (ventriculostomy dual-function): ICP >20 mmHg indicates need for intervention
• Cerebral perfusion pressure (CPP = MAP - ICP): Target CPP 60-70 mmHg

Acute Stabilization and Supportive Care

• Airway protection: Intubation if GCS ≤8 (aspiration risk, airway protection, hyperventilation capability)
• Adequate oxygenation: Target SpO₂ >95%; avoid hypoxemia worsening cerebral edema
• Blood pressure management (target-dependent on etiology):
• For hypertensive hemorrhage: Target SBP <180 mmHg using IV agents (preferred over oral)
• IV labetalol: 10-20 mg IV push, repeated every 10 minutes (max 220 mg); safe first-line agent
• IV nicardipine: 5 mg/hour infusion, titrate by 2.5 mg/hour every 5-15 minutes (target <180 mmHg)
• IV esmolol: 500 μg/kg bolus then infusion for acute hypertensive crisis
• Avoid aggressive BP lowering in first 24 hours (cerebral autoregulation impaired; hematoma expansion risk reduced but not eliminated)

Reversal of Anticoagulation (Time-Sensitive)

• Warfarin reversal:
• Fresh frozen plasma (FFP): 10-15 mL/kg IV; slow onset (24 hours), volume overload risk
• Prothrombin complex concentrate (PCC): 25-50 units/kg IV (preferred); faster reversal than FFP
• Vitamin K: 10 mg IV slowly; takes 12-24 hours for effect (use adjunctively with PCC/FFP)

• DOAC reversal:
• Idarucizumab (for dabigatran): 5 g IV (2 doses of 2.5 g); reverses anticoagulation within minutes
• Apixaban/rivaroxaban: Andexanet alfa (Factor Xa inhibitor antidote): 800 mg bolus then 960 mg/hour infusion; limited availability, expensive
• Consider PCC 25-50 units/kg as bridging if specific reversal agents unavailable

• Heparin reversal: Protamine sulfate 1 mg IV per 100 units of heparin (max 50 mg single dose)

Thrombocytopenia Management

• Platelet transfusion: Target >30,000/μL (some experts recommend >50,000/μL acutely); transfuse only if active bleeding or count <10,000/μL
• Avoid routine transfusion (association with worse outcomes in observational studies, likely from transfusion-related immune activation)

Hemostatic Agents

• Tranexamic acid (TXA): 1 g IV bolus, then 1 g IV infusion over 8 hours within 3 hours of symptom onset
• Antifibrinolytic agent reduces hematoma expansion; modest mortality benefit in ICH population (TICH-2 trial)
• Avoid if seizure history (increases seizure risk)

• Recombinant Factor VIIa: 80 μg/kg IV; limited evidence, increases thromboembolism risk; use reserved for severe coagulopathy unresponsive to conventional reversal

Management of Obstructive Hydrocephalus

• External ventricular drain (EVD) placement: Ventriculostomy indicated for:
• Severe IVH (Graeb >II) with significant ventricular obstruction
• GCS ≤8 with midline shift
• Clinical deterioration from raised intracranial pressure
• Allows simultaneous ICP monitoring and CSF drainage
• Optimal drain height: 10-15 cm above tragus (balance between drainage and ICP monitoring)
• Monitor for ventriculitis (fever, elevated CSF protein/WBC); change dressing q48-72h

• Ventricular lavage: Controversial; small RCTs show reduced intraventricular clot burden but unclear mortality benefit; may consider in massive IVH

Seizure Prophylaxis

• Phenytoin or levetiracetam: Prophylactic seizure management in high-risk patients (cortical involvement, early seizure)
• Short-term use (7-14 days) preferred; long-term use associated with worse outcomes (cognitive impairment)
• Phenytoin: 15-20 mg/kg IV load, then 5 mg/kg/day divided TID
• Levetiracetam: 500-1000 mg IV BID preferred (fewer drug interactions)

Neuroinflammation and Neuroprotection

• Mannitol or hypertonic saline (3% NaCl): For acute intracranial pressure elevation
• Mannitol: 0.5-1 g/kg IV q4-6h (osmotic agent; rebound ICP elevation possible)
• 3% saline: 5 mL/kg IV bolus; preferred in hypotensive patients
• Target osmolality <320 mOsm/kg

• Head of bed elevation: 30 degrees to optimize cerebral venous drainage
• Temperature control: Maintain normothermia; fever worsens outcomes (target 36.5-37°C)
• Blood glucose control: Strict glycemic control (100-180 mg/dL); hyperglycemia worsens prognosis
• Sedation/analgesia: Propofol or midazolam for patient comfort and ICP control (reduces respiratory drive variability)

Anticoagulation Resumption

• Timing depends on hemorrhage severity and indication:
• Mechanical heart valve: Resume anticoagulation at 7-10 days (high thromboembolism risk if delayed)
• Atrial fibrillation: Delay 2-4 weeks if possible (lower embolic risk than mechanical valves)
• Assess baseline IVH volume, stability, and whether hemorrhage expansion risk remains
• Restart **DOAC preferred over warfarin

Immediate emergencies

• Acute obstructive hydrocephalus with herniation: clot plugging the foramina of Monro, aqueduct, or fourth-ventricular outlets blocks CSF egress while production continues. Signaled by abrupt GCS drop, new anisocoria or bilateral fixed pupils, Cushing reflex (hypertension + bradycardia + irregular respirations). Requires emergent CSF diversion (external ventricular drain) per the AHA/ASA spontaneous intracerebral hemorrhage guideline.
• Hematoma expansion / rebleeding: greatest in the first hours, especially with coagulopathy or uncontrolled systolic pressure; heralded by neurologic deterioration and larger volume on repeat non-contrast CT. If an aneurysm is the source, rebleeding is the leading early cause of death — secure the aneurysm (AHA/ASA aneurysmal SAH guideline).
• Seizures and nonconvulsive status epilepticus: cortical irritation by blood and iron. Depressed consciousness out of proportion to imaging warrants continuous EEG.
• EVD-related ventriculitis: fever, CSF pleocytosis with falling glucose, rising drain output turbidity. An emergency — treat as healthcare-associated ventriculitis per IDSA guidance. Catheter-tract hemorrhage and drain obstruction are additional device complications.

Subacute and delayed

• Communicating post-hemorrhagic hydrocephalus: hemosiderin and arachnoid fibrosis impair CSF absorption weeks later → gait apraxia, incontinence, cognitive slowing; often shunt-dependent, with later shunt infection or obstruction.
• Neonatal post-hemorrhagic ventricular dilation: accelerating head circumference crossing percentiles, full/tense fontanelle, splayed sutures, sunsetting eyes, apnea and bradycardia. Serial cranial ultrasound tracks ventricular index.
• Periventricular hemorrhagic infarction (grade IV): venous congestion of the medullary veins draining into the germinal matrix, not simple blood extension — leaves a porencephalic cyst and contralateral hemiparesis.
• Periventricular leukomalacia: ischemic white-matter necrosis of the watershed periventricular zone; because corticospinal fibers to the legs run closest to the ventricle, the classic sequela is spastic diplegia.
• Systemic: acute anemia and hypotension in neonates, later indirect hyperbilirubinemia from resorbing blood; hyponatremia from SIADH versus cerebral salt wasting (volume status distinguishes them); venous thromboembolism from immobility.

• Germinal matrix is the source in preterm IVH: a highly vascular, thin-walled subependymal zone at the caudothalamic groove that involutes by roughly 32–34 weeks. This is why risk falls sharply with advancing gestational age and why IVH is rare at term.
• Pressure-passive cerebral circulation is the mechanism: the sick preterm brain lacks autoregulation, so hypotension, fluid boluses, hypercarbia, suctioning, and pneumothorax translate directly into swings of cerebral blood flow across fragile matrix vessels.
• Single best next step in a preterm infant with a falling hematocrit, bulging fontanelle, apnea, or seizures: bedside cranial ultrasound through the anterior fontanelle — portable, no radiation, no transport. Do not order CT first. Routine screening ultrasound in very preterm infants (per AAP/AAN-endorsed practice) is why many cases are found in asymptomatic babies.
• Papile grading is the tested classification: I = germinal matrix only; II = intraventricular blood without ventricular dilation; III = IVH with ventricular dilation; IV = periventricular hemorrhagic (venous) infarction. Grades I–II usually do well; III–IV drive cerebral palsy and cognitive impairment.
• The association examiners love: antenatal corticosteroids (betamethasone) for anticipated preterm birth reduce IVH along with respiratory distress syndrome — an ACOG recommendation; delayed cord clamping is also recommended and is associated with less IVH.
• Classic buzzwords: catastrophic deterioration with bulging fontanelle and falling hematocrit; sunsetting eyes and head circumference crossing percentiles for post-hemorrhagic hydrocephalus; spastic diplegia for periventricular leukomalacia.
• Common distractor 1: grade IV is not "blood extending from the ventricle into brain" — it is venous infarction of periventricular white matter, and PVL is a separate ischemic lesion that can occur without any hemorrhage.
• Common distractor 2: in the adult with thunderclap headache and ventricular blood, lumbar puncture is not the next step — obtain non-contrast CT, then vascular imaging (CTA) to exclude aneurysm or AVM.